Registro local de enfermedad renal crónica y portadores de un aloinjerto renal funcional
| datacite.rights | http://purl.org/coar/access_right/c_16ec | spa |
| dc.contributor.advisor | Cabarcas Barbosa, Omar | |
| dc.contributor.advisor | Guido Musso, Carlos | |
| dc.contributor.author | Puche Carrascal, Eduardo José | |
| dc.date.accessioned | 2023-02-07T14:32:27Z | |
| dc.date.available | 2023-02-07T14:32:27Z | |
| dc.date.issued | 2023 | |
| dc.description.abstract | Siendo el trasplante renal la terapia de reemplazo renal con mayor costo-efectividad, no está exenta de presentar complicaciones que afecten la supervivencia del injerto y la mortalidad del paciente, por lo cual un aspecto clave para la consecución de desenlaces favorables no solamente es la valoración pretrasplante y lo que concierne al perioperatorio, también es fundamental hacer un seguimiento longitudinal estrecho y periódico para garantizar el éxito del trasplante renal a largo plazo. En una etapa de cambios tecnológicos, se hace prioritario adaptarnos a esta transición y obtener los beneficios que este cambio trae consigo. La creación de una base de datos tipo CRF (formulario de registro de casos), permitirá el fácil registro y acceso a la información de los pacientes trasplantados con el fin de determinar variables que puedan influir directa o indirectamente en los diferentes desenlaces ya sean negativos o positivos, esto con el objetivo de definir relaciones de causalidad y a futuro incluso intervenciones que afecten de forma benéfica al paciente y prolonguen la supervivencia del injerto. Adicionalmente, entre las variables registradas se encuentran aquellas que la Cuenta de Alto Costo (CAC) del Sistema General de Seguridad Social en Salud de Colombia (SGSSS) exige, favoreciendo con este CRF la extracción de datos específicos requeridos por este organismo, siendo este asunto un punto crítico para estabilizar el sistema de salud y garantizar así el adecuado funcionamiento del mismo. | spa |
| dc.description.abstract | Since kidney transplantation is the most cost-effective renal replacement therapy, it is not exempt from presenting complications that affect graft survival and patient mortality. Therefore, a key aspect for achieving favorable outcomes is not only the pre-transplant assessment and what concerns the perioperative period, a close and periodic longitudinal follow-up is essential to also guarantee the success of the kidney transplant in the long term. In a stage of technological changes, it is a priority to adapt to this transition and obtain the benefits that this change brings. The creation of a CRF-type database (case registration form) will allow easy registration and access to information on transplant patients in order to determine the variables that can directly or indirectly influence the different outcomes, whether they are negative or positive, this with the aim of defining causality relationships and in the future even interventions that beneficially affect the patient and prolong graft survival. Additionally, among the registered variables are those that the High Cost Account (CAC) of the General System of Social Security in Health of Colombia (SGSSS) requires, favoring with this CRF the extraction of specific data required by this organism, this matter being a critical point to stabilize the health system and thus ensure its proper functioning. | eng |
| dc.format.mimetype | spa | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12442/11810 | |
| dc.language.iso | spa | spa |
| dc.publisher | Ediciones Universidad Simón Bolívar | spa |
| dc.publisher | Facultad de Ciencias de la Salud | spa |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | eng |
| dc.rights.accessrights | info:eu-repo/semantics/restrictedAccess | spa |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.subject | Aloinjerto renal | spa |
| dc.subject | Trasplante renal | spa |
| dc.subject | Enfermedad renal crónica | spa |
| dc.subject | Cuenta de alto costo | spa |
| dc.subject | CRF | spa |
| dc.subject | Kidney allograft | eng |
| dc.subject | Kidney transplant | eng |
| dc.subject | Chronic kidney disease | eng |
| dc.subject | High cost account | eng |
| dc.title | Registro local de enfermedad renal crónica y portadores de un aloinjerto renal funcional | spa |
| dc.type.driver | info:eu-repo/semantics/other | spa |
| dc.type.spa | Otros | spa |
| dcterms.references | M. O. Valentín, A. Pérez Blanco, R. Marazuela, et al.Legislación, ética y trasplante renal. Organización Nacional de Trasplantes. Madrid. España. Archivos españoles de urología. 2021; 74 (10): 910-921. | spa |
| dcterms.references | Michelle L, Ekamol T, Miklos Z. The failing kidney allograft: A review and recommendations for the care and management of a complex group of patients. American Journal of Transplantation. 2021;21:2937–2949. DOI: 10.1111/ajt.16717 | eng |
| dcterms.references | Webster AC, Nagler E V., Morton RL, Masson P. Chronic Kidney Disease. Lancet [Internet]. 2017;389(10075):1238–52. Available from: http://dx.doi.org/10.1016/S0140-6736(16)32064-5 | eng |
| dcterms.references | KDIGO. Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl [Internet]. 2013;3(1):9. Available from: https://kdigo.org/wp-content/uploads/2017/02/KDIGO_2012_CKD_GL.pdf | eng |
| dcterms.references | Shan Shan Chen, Saleem Al Mawed, Mark Unruh. Health-Related Quality of Life in End-Stage Renal Disease Patients: How Often Should We Ask and What Do We Do with the Answer?. Blood Purifification 2016;41:218–224. DOI: 10.1159/000441462. | eng |
| dcterms.references | Iyasere O, Brown EA. Determinants of quality of life in advanced kidney disease: Time to screen? Postgrad Med J. 2014;90(1064):340–7. | eng |
| dcterms.references | Salud IN de. Situación del trasplante renal en Colombia - Cuenta de alto costo. 2015;1–66. Available from: https://cuentadealtocosto.org/site/images/Publicaciones/Situacion_del_Trasplante_Renal_en_Colombia_2015.pdf | spa |
| dcterms.references | Kaya B, Erturk D, Paydas S, Demir E, Balal M, Gocum H. Evaluation of Living Kidney Donor and Recipient Candidates: The Experience of Our Center. Transplant Proc [Internet]. 2019;51(7):2205–9. Available from: https://doi.org/10.1016/j.transproceed.2019.04.071 | eng |
| dcterms.references | Martín Moreno PL, Errasti P. Trasplante renal. An Sist Sanit Navar. 2006;29(SUPPL. 2):79–92. | spa |
| dcterms.references | Esteve AF, Cotilla E, Roca S, Jiménez L, Paya JS, Sillero C, et al. Evolución de receptores de trasplante renal de alto y bajo riesgo inmunológico sometidos a diferente inmunosupresión. Nefrologia. 2009;29(6):557–61. | spa |
| dcterms.references | Kalluri HV. Current state of renal transplant immunosuppression: Present and future. World J Transplant. 2012;2(4):51. | eng |
| dcterms.references | MEHRA N, CHOPRA G. Importance of Donor Selection in Renal Transplantation. Med J Armed Forces India [Internet]. 1994;50(3):205–10. Available from: http://dx.doi.org/10.1016/S0377-1237(17)31063-8 | eng |
| dcterms.references | Lentine KL, Kasiske BL, Levey AS, Adams PL, Alberú J, Bakr MA, et al. KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors. Vol. 101, Transplantation. 2017. 1–109 p. | eng |
| dcterms.references | Marbun MBH, Susalit E, Umami V. 7 Years Experience of Living Donor Kidney Transplantation in Indonesia: A Retrospective Cohort Study. Acta Med Indones. 2018;50(2):119–24. | eng |
| dcterms.references | Shahbazi F, Ranjbaran M, Karami-Far S, Soori H, Manesh HJ. Graft survival rate of renal transplantation during a period of 10 years in Iran. J Res Med Sci. 2015;20(11):1046–52. | eng |
| dcterms.references | Hidalgo RÁ. El criterio inmunológico de selección para el trasplante renal: Un aspecto científico-ético. | spa |
| dcterms.references | Pratschke J, Dragun D, Hauser IA, Horn S, Mueller TF, Schemmer P, et al. Immunological risk assessment: The key to individualized immunosuppression after kidney transplantation. Transplant Rev [Internet]. 2016;30(2):77–84. Available from: http://dx.doi.org/10.1016/j.trre.2016.02.002 | eng |
| dcterms.references | Gómez-Carracedo A, Arias-Muñana E, Jiménez-Rojas C. Tratado de Geriatría y Gerontología. Insuficiencia Renal Crónica. 2006;[637-46]. Available from: https://www.segg.es/tratadogeriatria/main.html | spa |
| dcterms.references | Of H, Cident IN, Modalities R. Chapter 1: Incidence, Prevalence, Patient Characteristics, and Treatment Modalities. Am J Kidney Dis. 2019;73(3):S291–332. | eng |
| dcterms.references | Perl J. Kidney transplant failure: Failing kidneys, failing care? Clin J Am Soc Nephrol. 2014;9(7):1153–5. | eng |
| dcterms.references | Ocharan Corcuera J. Cuidados paliativos en la enfermedad renal crónica. Gac médica Bilbao Rev Of la Acad Ciencias Médicas Bilbao. 2015;112(4):5. | spa |
| dcterms.references | Sanidad DE, Social B. trasplantes en españa. Rev Iberoam Fertil y Reprod Humana. 2018;33(1):49. | eng |
| dcterms.references | Martín Escobar E. Registro Español de Enfermos Renales. Informe 2013 y evolución 2007-2013. Nefrología. 2016;36(2):97–120. | spa |
| dcterms.references | Instituto Nacional de Salud. Informe ejecutivo preliminar, Red Nacional de Donación y Trasplantes - Información trasplante de órganos 2017. 2017;15. Available from: https://www.ins.gov.co/Noticias/SiteAssets/Paginas/FORO-TRASPLANTE-EN-COLOMBIA-UNA-ESPERANZA-DE-VIDA/INFORME PRELIMINAR 2017.pdf | spa |
| dcterms.references | Ghoneim MA, Bakr MA, Refaie AF, Akl AI, Shokeir AA, Shehab El-Dein AB, et al. Factors affecting graft survival among patients receiving kidneys from live donors: A single-center experience. Biomed Res Int. 2013;2013. | eng |
| dcterms.references | Haller MC, Kainz A, Baer H, Oberbauer R. Dialysis vintage and outcomes after kidney transplantation: A retrospective cohort study. Clin J Am Soc Nephrol. 2017;12(1):122–30. | eng |
| dcterms.references | Jalalzadeh M, Mousavinasab N, Peyrovi S, Ghadiani MH. The impact of acute rejection in kidney transplantation on long-term allograft and patient outcome. Nephrourol Mon. 2015;7(1):7–11. | eng |
| dcterms.references | Sapir-Pichhadze R, Young A, Kim SJ. Living donor age and kidney transplant outcomes: An assessment of risk across the age continuum. Transpl Int. 2013;26(5):493–501. | eng |
| dcterms.references | Pisavadia B, Arshad A, Chappelow I, Nightingale P, Anderson B, Nath J, et al. Ethnicity matching and outcomes after kidney transplantation in the United Kingdom. PLoS One. 2018;13(4):1–14. | eng |
| dcterms.references | Davis S, Cooper JE. Acute antibody-mediated rejection in kidney transplant recipients. Transplant Rev [Internet]. 2017;31(1):47–54. Available from: http://dx.doi.org/10.1016/j.trre.2016.10.004 | eng |
| dcterms.references | Cubillos Gutiérrez J, Sandoval Riveros CL, Andrade Cerquera E, Hermida Gutiérrez NH. Causas que contribuyen a la pérdida del trasplante renal de donante cadavérico en la Fundación Surcolombiana de Trasplantes. Febrero 2007 a noviembre de 2012, Neiva, Colombia. Rev Colomb Anestesiol. 2014;42(2):83–9. | spa |
| dcterms.references | Schnuelle P, Lorenz D, Trede M, Van Der Woude FJ. Impact of renal cadaveric transplantation on survival in end-stage renal failure: Evidence for reduced mortality risk compared with hemodialysis during long-term follow-up. J Am Soc Nephrol. 1998;9(11):2135–41. | eng |
| dcterms.references | Marrero DH, Alcaide MG. Resultados globales del trasplante renal. Nefrologia [Internet]. 2010;80(Tabla 2). Available from: http://www.revistanefrologia.com/es-publicacion-nefrologia-articulo-resultados-globales-del-trasplante-renal-XX342164212000058 | spa |
| dcterms.references | Knoll G, Cockfield S, Blydt-hansen T, Baran D, Kiberd B, Landsberg D. Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation. Cmaj. 2005;173(10):1181–4. | eng |
| dcterms.references | Harrison EM, Oniscu GC, Forsythe JL. Equity of access to kidney transplantation: To what extent should international guidelines differ? Transplantation. 2012;94(7):669–70. | eng |
| dcterms.references | Bunnapradist S, Danovitch GM. Evaluation of Adult Kidney Transplant Candidates. Am J Kidney Dis. 2007;50(5):890–8. | eng |
| dcterms.references | Steinman TI, Becker BN, Frost AE, Olthoff KM, Smart FW, Suki WN, et al. Guidelines for the referral and management of patients eligible for solid organ transplantation. Transplantation. 2001;71(9):1189–204. | eng |
| dcterms.references | Abramowicz D, Cochat P, Claas FHJ, Heemann U, Pascual J, Dudley C, et al. European Renal Best Practice Guideline on kidney donor and recipient evaluation and perioperative care. Nephrol Dial Transplant. 2015;30(11):1790–7. | eng |
| dcterms.references | Nikodimopoulou M, Karakasi K, Daoudaki M, et al. Kidney Transplantation in Old Recipients From Old Donors: A Single-Center Experience. Transplantation Proceedings (2019), 51(2), 405–407. doi:10.1016/j.transproceed.2019.01.019 | eng |
| dcterms.references | Journal A. Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients. Am J Transplant. 2009;9(Suppl 3):S1–155. | eng |
| dcterms.references | Furness PN, Philpott CM, Chorbadjian MT, Nicholson ML, Bosmans JL, Corthouts BL, et al. Protocol biopsy of the stable renal transplant: A multicenter study of methods and complication rates. Transplantation. 2003;76(6):969–73. | eng |
| dcterms.references | Hart A, Smith JM, Skeans MA, Gustafson SK, Stewart DE, Cherikh WS, et al. KIDNEY. Am J Transpl. 2016;16(2):11–46. | eng |
| dcterms.references | Uceta RP, Sansano EL, Jurado JIA, Sánchez GB, Velasco MÁG, Moreno MIB. Tratamiento del rechazo agudo hiperinmune con plasmaféresis y rituximab. Nuestra experiencia. Enferm Nefrol. 2012;15(2):146–50. | eng |
| dcterms.references | Organización Panamericana de la Salud. Perfil De Los Sistemas De Salud. Colombia. Vol. 3, Biblioteca OPS. 2008. 1–56 p. | spa |
| dcterms.references | Guerrero R, Gallego AI, Becerril-Montekio V, Vásquez J. Sistema de salud de Colombia. Salud Publica Mex. 2011;53(SUPPL. 2). | spa |
| dcterms.references | AM Yazmín, OA Karime, et al. Seroprevalencia de citomegalovirus en donantes de órganos y receptores de trasplante renal, Colombia, 2010-2014. Biomédica 2016;36(Supl.2):187-93doi: http://dx.doi.org/10.7705/biomedica.v36i0.2938 | spa |
| oaire.version | info:eu-repo/semantics/acceptedVersion | spa |
| sb.programa | Especialización en Nefrología | spa |
| sb.sede | Sede Barranquilla | spa |